JenaValve Technology
Organization
People
John Kilcoyne
Chief Executve Officer
Sources: sec.gov
Board
Jan Pensaert
Board director
Daniel Dearen
Board director
Kenneth MacLeod
Board director
Olivier Litzka
Board director
Andrew Hack
Board director
Keith Dawkins
Board director
Jan Keltjens
Board director
John Kilcoyne
Board director
Sources: sec.gov
Based in
United States
Sources: sec.gov
Trials
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
Recruiting, 1,016 people, Sep 23, 2024
The JenaValve ALIGN-AR LVAD Registry
Active, not recruiting, 50 people, Sep 19, 2024
Sources: clinicaltrials.gov
Funding rounds
Form D
$100M, Dec 21, 2021
Venture
$50M, Feb 5, 2020
Form D
$14.5M, Jun 6, 2019
Form D
$9.4M, Jul 20, 2017
Form D
$10M, Jul 29, 2016
Form D
$26.5M, Jul 23, 2015
Form D
$73.4M, Jul 19, 2013
Form D
$13.5M, Mar 1, 2010
Sources: sec.gov, news.google.com
Investors
Venture, Feb 5, 2020
Venture, Feb 5, 2020
Venture, Feb 5, 2020
Venture, Feb 5, 2020
Venture, Feb 5, 2020
Venture, Feb 5, 2020
Venture, Feb 5, 2020
Venture, Lead, Feb 5, 2020
Sources: pulse2.com